• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扫描时间缩短对人类 C-PHNO 与多巴胺 D 受体结合的影响及复测信度。

Effect of scan-time shortening on the C-PHNO binding potential to dopamine D receptor in humans and test-retest reliability.

机构信息

Department of Molecular Imaging in Medicine, Graduate School of Medicine, Osaka University, 2-1, Yamadaoka, Suita, Osaka, 565-0871, Japan.

Shionogi & Co., Ltd, 1-8, Doshomachi 3-Chome, Chuo-ku, Osaka, 541-0045, Japan.

出版信息

Ann Nucl Med. 2023 Apr;37(4):227-237. doi: 10.1007/s12149-022-01819-4. Epub 2023 Jan 19.

DOI:10.1007/s12149-022-01819-4
PMID:36656501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10060283/
Abstract

OBJECTIVE

C-PHNO is a PET radioligand most specific to dopamine D receptor (DR). The long scan duration of 120 min used in quantification of C-PHNO binding to DR in previous studies is challenging to subjects. The main objective of this study was to investigate the effects of shorter scan times on the binding of C-PHNO to DR and test-retest reliability using the latest digital whole-body PET system.

METHODS

Two 120-min C-PHNO brain scans were performed in 7 healthy subjects using a digital whole-body PET/CT. The binding potential relative to non-displaceable tracer in the tissue (BP) of DR-rich regions: the pallidum, ventral striatum (VST), substantia nigra (SN) and hypothalamus, were quantified using the simplified reference tissue model. The bias, correlation, and test-retest reliability of BP, which includes the test-retest variability (TRV) and intraclass correlation coefficient (ICC), were evaluated and compared between scans of shorter durations (40-110 min post-injection) and the original 120-min scan acquisitions.

RESULTS

Progressively, shorter scan durations were associated with underestimation of BP, slightly decreased correlation with 120-min derived BP, and decrease in test-retest reliability. The BP values of the pallidum, VST and SN from the shortened 90-min scans showed excellent correlation with those derived from the 120-min scans (determination coefficients > 0.98), and the bias within 5%. The test-retest reliability of BP in these regions derived from 90-min scan (TRV of 3% in the VST and pallidum, 7% in the SN and the ICC exceeded 0.88) was comparable to those obtained in previous 120-min studies using brain-dedicated PET scanners. In the hypothalamus, the BP values obtained from scan-time less than 110 min showed bias larger than 5% and the TRV more than 9%.

CONCLUSION

The scan-time shortening causes bias and decreasing test-retest reliability of C-PHNO BP. However, in the whole-body PET system, 90-min scan duration was sufficient for estimating the C-PHNO BP in the DR-rich striatum and SN with small bias and at the test-retest reliability comparable to those derived from 120-min scans using the brain-dedicated PET systems.

摘要

目的

C-PHNO 是一种对多巴胺 D 受体(DR)具有最高特异性的 PET 示踪剂。先前研究中,对 C-PHNO 与 DR 结合的定量分析需要长达 120 分钟的扫描时长,这给受试者带来了挑战。本研究的主要目的是探讨使用最新的全身数字 PET 系统,缩短扫描时间对 C-PHNO 与 DR 结合的影响,以及测试-重测可靠性。

方法

对 7 名健康受试者进行了两次 120 分钟的 C-PHNO 脑部扫描,使用全身数字 PET/CT 完成。使用简化参考组织模型,对富含 DR 的区域(苍白球、腹侧纹状体(VST)、黑质(SN)和下丘脑)的组织中与不可置换示踪剂相比的结合潜能(BP)进行定量。评估并比较了较短(注射后 40-110 分钟)和原始 120 分钟扫描采集之间的 BP 偏倚、相关性和测试-重测可靠性,包括测试-重测变异性(TRV)和组内相关系数(ICC)。

结果

随着扫描时间的缩短,BP 值逐渐出现低估,与 120 分钟衍生 BP 的相关性略有下降,且测试-重测可靠性降低。来自缩短至 90 分钟的扫描的苍白球、VST 和 SN 的 BP 值与 120 分钟扫描的 BP 值具有极好的相关性(决定系数 > 0.98),且偏倚在 5%以内。来自 90 分钟扫描的这些区域的 BP 的测试-重测可靠性(VST 和苍白球的 TRV 为 3%,SN 的 TRV 为 7%,ICC 超过 0.88)与先前使用脑部专用 PET 扫描仪进行的 120 分钟研究中获得的结果相当。在下丘脑,扫描时间少于 110 分钟时获得的 BP 值的偏倚大于 5%,且 TRV 大于 9%。

结论

扫描时间缩短会导致 C-PHNO BP 的偏倚和测试-重测可靠性降低。然而,在全身 PET 系统中,90 分钟的扫描时长足以用于估计富含 DR 的纹状体和 SN 中的 C-PHNO BP,其偏倚较小,与使用脑部专用 PET 系统进行 120 分钟扫描的结果相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c3/10060283/7fc84955966a/12149_2022_1819_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c3/10060283/a4a874b46917/12149_2022_1819_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c3/10060283/c46bec11fa23/12149_2022_1819_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c3/10060283/e60ac8f44d39/12149_2022_1819_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c3/10060283/990806e45d11/12149_2022_1819_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c3/10060283/828b3537698b/12149_2022_1819_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c3/10060283/7fc84955966a/12149_2022_1819_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c3/10060283/a4a874b46917/12149_2022_1819_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c3/10060283/c46bec11fa23/12149_2022_1819_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c3/10060283/e60ac8f44d39/12149_2022_1819_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c3/10060283/990806e45d11/12149_2022_1819_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c3/10060283/828b3537698b/12149_2022_1819_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c3/10060283/7fc84955966a/12149_2022_1819_Fig6_HTML.jpg

相似文献

1
Effect of scan-time shortening on the C-PHNO binding potential to dopamine D receptor in humans and test-retest reliability.扫描时间缩短对人类 C-PHNO 与多巴胺 D 受体结合的影响及复测信度。
Ann Nucl Med. 2023 Apr;37(4):227-237. doi: 10.1007/s12149-022-01819-4. Epub 2023 Jan 19.
2
Age-related changes in binding of the D2/3 receptor radioligand [(11)C](+)PHNO in healthy volunteers.健康志愿者中D2/3受体放射性配体[(11)C](+)PHNO结合的年龄相关变化。
Neuroimage. 2016 Apr 15;130:241-247. doi: 10.1016/j.neuroimage.2016.02.002. Epub 2016 Feb 11.
3
Regional and source-based patterns of [C]-(+)-PHNO binding potential reveal concurrent alterations in dopamine D and D receptor availability in cocaine-use disorder.基于区域和来源的[C]-(+)-PHNO结合潜能模式揭示了可卡因使用障碍中多巴胺D1和D2受体可用性的同时改变。
Neuroimage. 2017 Mar 1;148:343-351. doi: 10.1016/j.neuroimage.2017.01.045. Epub 2017 Jan 19.
4
Parametric Imaging and Test-Retest Variability of ¹¹C-(+)-PHNO Binding to D₂/D₃ Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner.¹¹C-(+)-PHNO与人类D₂/D₃多巴胺受体结合在高分辨率研究型断层PET扫描仪上的参数成像及重测变异性
J Nucl Med. 2014 Jun;55(6):960-6. doi: 10.2967/jnumed.113.132928. Epub 2014 Apr 14.
5
Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.与健康对照相比,抽动秽语综合征成人患者纹状体D2/D3多巴胺受体可用性相似:一项[(11)C]-(+)-PHNO和[(11)C]雷氯必利正电子发射断层扫描成像研究。
Hum Brain Mapp. 2015 Jul;36(7):2592-601. doi: 10.1002/hbm.22793. Epub 2015 Mar 18.
6
Dopamine D receptor availability in cocaine use disorder individuals with obesity as measured by [C]PHNO PET.使用 [C]PHNO PET 测量肥胖的可卡因使用障碍个体中的多巴胺 D 受体可用性。
Drug Alcohol Depend. 2021 Mar 1;220:108514. doi: 10.1016/j.drugalcdep.2021.108514. Epub 2021 Jan 8.
7
Dopamine D2/D3 receptor abnormalities after traumatic brain injury and their relationship to post-traumatic depression.创伤性脑损伤后多巴胺 D2/D3 受体异常及其与创伤后抑郁的关系。
Neuroimage Clin. 2019;24:101950. doi: 10.1016/j.nicl.2019.101950. Epub 2019 Jul 22.
8
Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [(11)C]-(+)-PHNO.抗精神病药物与人类多巴胺-3受体的结合:一项使用[(11)C]-(+)-PHNO的正电子发射断层扫描研究。
Schizophr Res. 2015 Oct;168(1-2):373-6. doi: 10.1016/j.schres.2015.06.027. Epub 2015 Jul 17.
9
Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist.正电子发射断层扫描(PET)、[11C]PHNO 和选择性 D3 受体拮抗剂在人脑中成像多巴胺 D3 受体。
Biol Psychiatry. 2010 Aug 15;68(4):392-9. doi: 10.1016/j.biopsych.2010.04.038.
10
A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [(11)C](+)PHNO.使用[(11)C](+)PHNO对健康人和可卡因依赖者进行成像的多巴胺D2/3受体可用性与社会地位的初步研究。
Drug Alcohol Depend. 2015 Sep 1;154:167-73. doi: 10.1016/j.drugalcdep.2015.06.039. Epub 2015 Jun 30.

本文引用的文献

1
Imaging Pituitary Vasopressin 1B Receptor in Humans with the PET Radiotracer C-TASP699.用 PET 放射性示踪剂 C-TASP699 对人类垂体加压素 1B 受体进行成像。
J Nucl Med. 2022 Apr;63(4):609-614. doi: 10.2967/jnumed.121.262430. Epub 2021 Aug 12.
2
Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders.神经元多巴胺D3受体:对临床前研究和中枢神经系统疾病的转化意义
Biomolecules. 2021 Jan 14;11(1):104. doi: 10.3390/biom11010104.
3
Evaluation of dopamine D receptor occupancy by blonanserin using [C]-(+)-PHNO in schizophrenia patients.
使用 [C]-(+)-PHNO 评估精神分裂症患者中布南色林对多巴胺 D 受体的占有率。
Psychopharmacology (Berl). 2021 May;238(5):1343-1350. doi: 10.1007/s00213-020-05698-3. Epub 2020 Nov 12.
4
Occupancy of dopamine D and D receptors by a novel D3 partial agonist BP1.4979: a [C]-(+)-PHNO PET study in humans.新型 D3 部分激动剂 BP1.4979占据多巴胺 D 和 D 受体:人类 [C]-(+)-PHNO PET 研究。
Neuropsychopharmacology. 2019 Jun;44(7):1284-1290. doi: 10.1038/s41386-018-0285-4. Epub 2018 Nov 30.
5
Performance Characteristics of the Digital Biograph Vision PET/CT System.Digital Biograph Vision PET/CT 系统的性能特点。
J Nucl Med. 2019 Jul;60(7):1031-1036. doi: 10.2967/jnumed.118.215418. Epub 2019 Jan 10.
6
Comparison of Dopamine D3 and D2 Receptor Occupancies by a Single Dose of Blonanserin in Healthy Subjects: A Positron Emission Tomography Study With [11C]-(+)-PHNO.健康受试者中单剂量布南色林与多巴胺 D3 和 D2 受体占有率的比较:使用 [11C]-(+)-PHNO 的正电子发射断层扫描研究。
Int J Neuropsychopharmacol. 2018 Jun 1;21(6):522-527. doi: 10.1093/ijnp/pyy004.
7
The dopamine D3 receptor, a quarter century later.25年后的多巴胺D3受体。
Eur J Neurosci. 2017 Jan;45(1):2-19. doi: 10.1111/ejn.13390. Epub 2016 Oct 3.
8
Guidelines to PET measurements of the target occupancy in the brain for drug development.药物研发中大脑目标占位PET测量指南。
Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2255-2262. doi: 10.1007/s00259-016-3476-4. Epub 2016 Aug 11.
9
Evaluation of semi-quantitative method for quantification of dopamine transporter in human PET study with ¹⁸F-FE-PE2I.¹⁸F-FE-PE2I在人体PET研究中用于多巴胺转运体定量的半定量方法评估。
Ann Nucl Med. 2015 Oct;29(8):697-708. doi: 10.1007/s12149-015-0993-3. Epub 2015 Jul 2.
10
BioImage Suite: An integrated medical image analysis suite: An update.生物图像套件:一个集成的医学图像分析套件:最新进展。
Insight J. 2006;2006:209.